Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 155† | 149† | 156† | 119† | 87† |
| Net profit | 11 | 4 | 7 | 11 | 5† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| SHANMUGAM HEMALATHA | Executive Director | June 30, 2026 |
| VINAYAK DINESH DENDUKURI | Executive Director | June 30, 2026 |
| PALAMADAI KRISHNAN SUNDARESAN | Independent Director | June 30, 2026 |
| RAVICHANDRAN CHITRA | Independent Director | June 30, 2026 |
| AKILA CHINTALAPATI RAJU | Non-Executive Director | June 30, 2026 |
| UPENDAR MEKALA REDDY | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
